Press Releases
Bioanalytical Laboratory Expansion at Its USA Headquarters Completed By BioAgilytix
Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has completed the expansion of the laboratory facility within its USA headquarters located in the Research Triangle area of North Carolina. ...
Press Releases
mProve Health and Greenphire Partner to Delivera First-of-its-Kind Patient Engagement Solution
mProve Health, a leading provider of mobile technologies for patient engagement and electronic clinical outcome assessments (eCOA), andGreenphire, the global leader in clinical payment automation, today announceda partnership to provide patients with real-time access to ClinCard payment detailsvia mProve’s...
Press Releases
FDA approves Mylotarg for treatment of acute myeloid leukemia
Pfizer Inc. announced that the U.S. Food and Drug Administration approved MYLOTARG™ (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory...
Press Releases
Aquavit Pharmaceuticals Adds New Patent To Its High-Tech Medical Portfolio
Aquavit Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office has issued a patent for Apollo Technology, System and Method for Personalized Injection Treatment. This follows Aquavit's European Patent issued by the European Patent...
Press Releases
Clinerion releases revamped design with improved functionality for Patient Recruitment System.
Clinerion has redesigned the web application for Patient Recruitment System, creating a sleek, professional and intuitive new user interface with analytical capabilities. The system’s functionality and speed have been improved, further supporting decision-making for clinical trial...
Press Releases
CDMO to invest €19m in GMP facility expansion
Spray drying specialist and capsule filling service provider Micro-Sphere is investing 21 million CHF (€19 million) into expanding its GMP manufacturing capabilities at its facility in Switzerland. The investment, which is in response to increased...
Press Releases
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules
RedHill Biopharma Ltd. , a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer. Announced that it has entered into a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read